CRAFT-A Proposed Framework for Decentralized Clinical Trials Participation in Canada

被引:33
作者
Sundquist, Stephen [1 ]
Batist, Gerald [2 ]
Brodeur-Robb, Kathy [3 ]
Dyck, Kathryn [4 ]
Eigl, Bernhard J. [5 ]
Lee, David K. [6 ]
Limoges, Jaqueline [7 ]
Longstaff, Holly [8 ]
Pankovich, Jim [9 ]
Sadura, Anna [10 ]
Sullivan, Patrick [11 ]
Dancey, Janet E. [1 ,10 ]
机构
[1] Canadian Canc Clin Trials Network, Toronto, ON M5G 0A3, Canada
[2] McGill Univ, Jewish Gen Hosp, Segal Canc Centre, Montreal, PQ H3T 1E2, Canada
[3] C17 Council Childrens Canc & Blood Disorders, Edmonton, AB T6G 1C9, Canada
[4] CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada
[5] BC Canc, Div Med Oncol, Vancouver, BC V5Z 4E6, Canada
[6] Hlth Canada, Hlth Prod & Food Branch, Ottawa, ON K1A 0K9, Canada
[7] Ontario Canc Res Eth Board, Toronto, ON M5G 0A3, Canada
[8] Prov Hlth Serv Author, Vancouver, BC V6H 4C1, Canada
[9] Bold Therapeut Inc, Vancouver, BC V6C 1E1, Canada
[10] Queens Univ, Canadian Canc Trials Grp, Kingston, ON K7L 3N6, Canada
[11] Team Finn Fdn, Vancouver, BC V7K 1V4, Canada
关键词
decentralized clinical trials; CRAFT; remote trial framework; trial cluster; remote trial management; remote trial access; Canada;
D O I
10.3390/curroncol28050329
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Canada's vast geography, and centralized delivery of cancer care and clinical trials create barriers for trial participation for patients in remote and rural settings. The development and implementation of a framework that enables safe and regulatory compliant trial participation through local healthcare providers would benefit Canadian patients, clinicians, trial sponsors and the health care system. To address this issue, representatives of Canada's cancer clinical trial community met to identify key challenges and develop recommendations for remote patient participation in trials. A structured literature review identified remote/rural trial delivery models. A panel of expert stakeholders reviewed the models and participated in a workshop to assess health system readiness, identify needed processes, tools and mechanisms, and develop recommendations for a Canadian framework for decentralized clinical trial conduct. The Canadian Remote Access Framework for clinical Trials (CRAFT) represents a risk-based approach used by site investigators to delegate responsibilities for a given trial to satellite health centres within a hub-and-spoke "trial cluster ". The Framework includes specific recommendations to ensure research experience, capacity, regulatory compliance and patient safety. Canada's cancer care and telemedicine systems can be leveraged to enable broader access to clinical trials for patients who are geographically remote from cancer centres. CRAFT's risk-based framework is based on other successful models of remote trial patient management and is in the pilot implementation phase in Canada.</p>
引用
收藏
页码:3857 / 3865
页数:9
相关论文
共 25 条
[1]   Pediatric oncology clinical trial participation where the geography is vast: Development of a clinical research system for tertiary and satellite centers in Ontario, Canada [J].
Alexander, Sarah ;
Greenberg, Mark ;
Malkin, David ;
Portwine, Carol ;
Johnston, Donna ;
Silva, Mariana ;
Zelcer, Shayna ;
Sonshine, Samantha ;
Manzo, Janet ;
Bennett, Carla ;
Brodeur-Robb, Kathy ;
Deveault, Catherine ;
Ramachandran, Nivetha ;
Gibson, Paul .
PEDIATRIC BLOOD & CANCER, 2018, 65 (04)
[2]  
American Cancer Society Cancer Action Network, 2018, Barriers to Patient Enrollment in Therapeutic Clinical Trials for Cancer: A Landscape Report
[3]   Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment [J].
Basch, Ethan ;
Deal, Allison M. ;
Dueck, Amylou C. ;
Scher, Howard I. ;
Kris, Mark G. ;
Hudis, Clifford ;
Schrag, Deborah .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (02) :197-198
[4]  
Canadian Partnership against Cancer, 2018, 2018 CANC SYST PERF
[5]  
Clinical Oncology Society of Australia, 2016, AUSTR TEL TRIAL MOD
[6]  
Clinical Oncology Society of Australia, 2021, PILOT IMPL AUSTR TEL
[7]  
Clinical Trials and Translational Research Advisory Committee, 2020, STRAT PLANN WORK GRO
[8]  
Clinical Trials Transformation Initiative, 2018, DEC CLIN TRIALS 2
[9]  
European Medicines Agency, 2021, GUID MAN CLIN TRIALS
[10]  
Federation of Medical Regulatory Authorities of Canada, FMRAC FRAM TEL